EnChannel Medical Guangzhou Inc. – Trademark Portfolio
Entity Type: 99
EnChannel Medical Guangzhou Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 16 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 4 are pending. Notable registered marks include PFLINE, LIBSTAR, LINKMAN, NAVSITE, and PFLOTUS. The owner is based in Guangzhou, Guangdong.
Room 901, Building C,
288 Shenzhou Road, Huangpu District,
Guangzhou, Guangdong 510700 , CN
Showing of trademarks Trademarks
Trademark Classifications
EnChannel Medical Guangzhou Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does EnChannel Medical Guangzhou Inc. have?
EnChannel Medical Guangzhou Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 12 registered, 4 pending, 2 abandoned.
What trademark classes does EnChannel Medical Guangzhou Inc. file in?
EnChannel Medical Guangzhou Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are EnChannel Medical Guangzhou Inc.'s most well-known trademarks?
EnChannel Medical Guangzhou Inc.'s registered trademark portfolio includes well-known marks such as PFLINE, LIBSTAR, LINKMAN, NAVSITE, and PFLOTUS. These are among 12 currently registered trademarks in the portfolio.
What is EnChannel Medical Guangzhou Inc.'s trademark registration success rate?
EnChannel Medical Guangzhou Inc. has a 86% trademark registration rate, with 12 out of 14 resolved applications resulting in successful registration. Currently, 4 applications are pending review.